Eclipse Bioinnovations, Inc.
Chimeric-eCLIP technology platform for transcriptome-wide microRNA target identification
- Sector
- Biotech
- Headquarters
- San Diego, CA
- Founded
- 2017
- Latest Form D
- $4.9M, Nov 2025
- Total capital
- $27M
- Federal grants
- $10.1M
- 11 awards · 2017–2026
- Rank in peer group#21 of 42
- Private capital raised
- $16.9M
- 2 Form D · last Nov 2025
- 11 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 2
- 20 pending · first 2023
- Rank in peer group#17 of 42
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · eMOA: A Multi-Omic Service for Mechanism of Action Determination in Drug Screening$824K
- Private capital raisedForm D · SEC · 2nd filing$4.9M
- Federal grantHealth and Human S · Phase II · eMOA: A Multi-Omic Service for Mechanism of Action Determination in Drug Screening$1.1M
- Federal grantHealth and Human S · Phase II · eMOA: A Multi-Omic Service for Mechanism of Action Determination in Drug Screening$296K
- Federal grantHealth and Human S · Phase II · Development of chimeric read amplification into a robust method for profiling targets of specific microRNAs and global amplification of all microRNA:mRNA pairings transcriptome-wide$862K
- Federal grantHealth and Human S · Phase II · Development of chimeric read amplification into a robust method for profiling targets of specific microRNAs and global amplification of all microRNA:mRNA pairings transcriptome-wide$1.1M
- Federal grantHealth and Human S · Phase II · Development of chimeric read amplification into a robust method for profiling targets of specific microRNAs and global amplification of all microRNA:mRNA pairings transcriptome-wide$2M
- Private capital raisedForm D · SEC · 1st filing$12M
Show 5 earlier federal awards
- Federal grantHealth and Human S · Phase I · Unambiguous transcriptome-wide identification of microRNA:mRNA interactions through enhanced chimeric read amplification$350K
- Federal grantHealth and Human S · Phase I · Unambiguous transcriptome-wide identification of microRNA:mRNA interactions through enhanced chimeric read amplification$350K
- Federal grantHealth and Human S · Phase II · A robust kit, standards, and software for identifying RNA binding protein targets$305K
- Federal grantHealth and Human S · Phase II · A robust kit, standards, and software for identifying RNA binding protein targets$1.6M
- Federal grantHealth and Human S · Phase II · A robust kit, standards, and software for identifying RNA binding protein targets$1.3M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
48months
from Eclipse Bioinnovations, Inc.’s first federal award to its first private round.
- First federal award · Sep 2017
- Health and Human S · $1.3M
- First Form D · Sep 2021
- $12M · 1st Form D
- Awards before first raise
- 5 awards
An association in public records, not a cause or a prediction.
Standing among 42 peers
Line = medianBiotech · Instrument
- Federal grants#21 · top 50%
- Granted patents#17 · top 40%
- Linked publications#3 · top 7%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Daniel L VasellaDirectorNamed in SEC Form D filings
- Edmond WongDirectorNamed in SEC Form D filings
- Eric L Van NostrandDirectorNamed in SEC Form D filings
- Eugene YeoDirectorNamed in SEC Form D filings
- Hallie L KuhnDirectorNamed in SEC Form D filings
- Peter ChuExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 2 granted of 22- GrantedMethods For Detecting Rna Binding Protein ComplexesUSPTOUS 12,460,257
- PendingMethods And Kits For Enriching For PolynucleotidesUSPTOApplication 18250423
- GrantedMethods For Detecting Rna Binding Protein ComplexesUSPTOUS 11,795,500
Show all 22 patent records
- Methods For Detecting Rna Binding Protein ComplexesNov 4, 2025 · US 12,460,257Granted
- Methods And Kits For Enriching For PolynucleotidesSep 19, 2024 · Application 18250423Pending
- Methods For Detecting Rna Binding Protein ComplexesOct 24, 2023 · US 11,795,500Granted
- Methods For Oligo Targeted Proximity LigationOct 5, 2023 · Application 18173644Pending
- Methods For Detecting Rna Modification Targets On A GeneSep 28, 2023 · Application 18148154Pending
- Methods For Detecting Rna TranslationAug 10, 2023 · Application 18148039Pending
- Kits And Methods For Enrichment Of Full-length RnaMay 4, 2023 · Application 17975259Pending
- Methods For Oligo Targeted Proximity LigationApplication 63313906Pending
- Methods For Detecting Rna TranslationApplication 63295317Pending
- Methods For Detecting Rna Binding Protein ComplexesApplication 63295296Pending
- Methods For Detecting Rna Modification Targets On A GeneApplication 63295357Pending
- Kits And Methods For Enrichment Of Full-length RnaApplication 63273001Pending
- Methods And Kits For Enriching For PolynucleotidesApplication PCTUS2021056471Pending
- Methods For Detecting Rna Binding Protein ComplexesApplication 63235070Pending
- Methods For Obtaining Rna Secondary Structure Of Lnp-encapsulated RnaApplication 18870946Pending
- Methods And Kits For Enriching For PolynucleotidesApplication 63105741Pending
- Methods For Obtaining Rna Secondary Structure Of Lnp-encapsulated RnaApplication PCTUS2023067794Pending
- Methods For Oligo Targeted Proximity LigationApplication PCTUS2023063116Pending
- Methods For Detecting Rna TranslationApplication PCTUS2022082481Pending
- Methods For Detecting Rna Modification Targets On A GeneApplication PCTUS2022082484Pending
- Methods For Detecting Rna Binding Protein ComplexesApplication PCTUS2022075122Pending
- Methods For Obtaining Rna Secondary Structure Of Lnp-encapsulated RnaApplication 63348738Pending
Recent research by its founders
- Meteotsunamis in the area of the South Kuril Islands: observations and numerical modeling20260 cites
- Meteotsunamis in the area of the Southern Kuril Islands: observations and numerical modeling20251 cites
- October 1, 2018, Meteotsunami in the South Kuril Islands Region20250 cites
Related companies, and why
- ACTINOBAC BIOMED, INC.Similar federal contract value in Biotech · null in contracts
- Resonate Industries IncSimilar federal contract value in Biotech · null in contracts
- OPUS GENETICS INC.Similar federal contract value in Biotech · null in contracts
- Reveal Pharmaceuticals, Inc.Similar federal contract value in Biotech · null in contracts
- COSMYC INCSimilar federal contract value in Biotech · null in contracts
- DEMERX, INC.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .